Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Vitamin C  COVID-19 treatment studies for Vitamin C  C19 studies: Vitamin C  Vitamin C   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 46% Improvement Relative Risk Bhowmik et al. Vitamin C for COVID-19 META ANALYSIS Favors vitamin C Favors control
Impact of high-dose vitamin C on the mortality, severity, and duration of hospital stay in COVID-19 patients: A meta-analysis
Bhowmik et al., Health Science Reports, doi:10.1002/hsr2.762 (meta analysis)
Bhowmik et al., Impact of high-dose vitamin C on the mortality, severity, and duration of hospital stay in COVID-19 patients:.., Health Science Reports, doi:10.1002/hsr2.762 (meta analysis)
Aug 2022   Source   PDF  
  All Studies   Meta
Meta analysis of 15 studies with 2,125 COVID-19 patients showing significantly lower mortality with high-dose vitamin C.
Currently there are 61 vitamin C studies and meta analysis shows:
Mortality20% lower [10‑29%]
Ventilation15% lower [-6‑32%]
ICU admission15% lower [0‑28%]
Hospitalization17% lower [4‑29%]
Cases6% more [-13‑30%]
risk of death, 46.0% lower, OR 0.54, p < 0.001, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Bhowmik et al., 8 Aug 2022, peer-reviewed, 4 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin CAll
Impact of high‐dose vitamin C on the mortality, severity, and duration of hospital stay in COVID‐19 patients: A meta‐analysis
Khokon Kanti Bhowmik, Md. Abdul Barek, Md. Abdul Aziz, Mohammad Safiqul Islam
Health Science Reports, doi:10.1002/hsr2.762
Background and Aims: Vitamin C has been predicted to be effective as an antioxidant in treating various ailments, including viral infections such as pervasive coronavirus disease (COVID-19). With this meta-analysis, we looked to ascertain the relationship between high-dose vitamin C administration and mortality, severity, and length of hospitalization of COVID-19 patients. Methods: We collected articles from PubMed, Google Scholar, ScienceDirect, SAGE, and Cochrane databases between January 1, 2020, and May 30, 2022. Odds ratio (ORs) with corresponding 95% confidence interval (CI) and p value were calculated to assess the connection of high-dose vitamin C in COVID-19 patients' mortality and severity. The length of hospitalization was calculated and pooled with the mean difference (MD), 95% CI, and p value. Review manager 5.3 was used to carry out this meta-analysis. Results: This meta-analysis included 15 complete studies involving 2125 COVID-19 patients. Our study demonstrated a significant correlation between vitamin C consumption and death. Vitamin C consumption significantly reduces mortality risk with COVID-19 patients (OR = 0.54, 95% CI = 0.42-0.69, p < 0.00001). Furthermore, there was a link between the severity of COVID-19 and the intake of vitamin C. Patients who consumed vitamin C showed 0.63 times less severity than those who did not take vitamin C (OR = 0.63, 95% CI = 0.43-0.94, p = 0.02). Patients taking vitamin C spent slightly more time in hospital than those who did not take vitamin C (MD = 0.19, 95% CI = −1.57 to 1.96, p = 0.83). Conclusions: During COVID-19, there was a substantial advantage in taking supplementary vitamin C, at least in terms of severity and mortality.
CONFLICT OF INTEREST The authors declare no conflict of interest. DATA AVAILABILITY STATEMENT The authors confirm that the data supporting the findings of this study are available within the article and/or its supplementary materials. TRANSPARENCY STATEMENT I, Mohammad S. Islam, the corresponding author of the referred article, declare that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and any discrepancies from the study as planned (and, if relevant, registered) have been explained. All authors have read and approved the final version of the manuscript. Mohammad Safiqul Islam had full access to all of the data in this study and takes complete responsibility for the integrity of the data.
Ahmad, Vitamin C for COVID-19 treatment: have we got enough evidence?, Front Nutr
Ao, Li, Yuan, Intravenous vitamin C use and risk of severity and mortality in COVID-19: a systematic review and metaanalysis, Nutr Clin Pract
Bakaev, Duntau, Ascorbic acid in blood serum of patients with pulmonary tuberculosis and pneumonia, Int J Tuberc Lung Dis
Barek, Aziz, Islam, Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: a meta-analysis with 55 studies and 10014 cases, Heliyon
Beigmohammadi, Bitarafan, Hoseindokht, Abdollahi, Amoozadeh et al., The effect of supplementation with vitamins A, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: a randomized clinical trial, Trials
Bhowmik, None
Calder, Carr, Gombart, Eggersdorfer, Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections, Nutrients
Carr, Maggini, Vitamin C and immune function, Nutrients
Carr, Rosengrave, Bayer, Chambers, Mehrtens et al., Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes, Crit Care
Carr, Rowe, The emerging role of vitamin C in the prevention and treatment of COVID-19, Nutrients
Cascella, Rajnik, Aleem, Dulebohn, Napoli, Features, Evaluation, and Treatment of Coronavirus (COVID-19)
Chen, Luo, Yuan, Vitamin C mitigates oxidative stress and tumor necrosis factor-alpha in severe community-acquired pneumonia and LPS-induced macrophages, Mediators Inflamm
Chernyak, Popova, Prikhodko, Grebenchikov, Zinovkina et al., COVID-19 and oxidative stress, Biochemistry
Darban, Malek, Memarian, Efficacy of high dose vitamin C, melatonin and zinc in Iranian patients with acute respiratory syndrome due to coronavirus infection: a pilot randomized trial, J Cell Mol Anesth
Du, Long, Tang, Liu, Dai et al., Prooxidative inhibition against NF-κB-mediated inflammation by pharmacological vitamin C, Free Radic Biol Med
Forcados, Muhammad, Oladipo, Makama, Meseko, Metabolic implications of oxidative stress and inflammatory process in SARS-CoV-2 pathogenesis: therapeutic potential of natural antioxidants, Front Cell Infect Microbiol
Furuya, Uozaki, Yamasaki, Arakawa, Arita et al., Antiviral effects of ascorbic and dehydroascorbic acids in vitro, Int J Mol Med
Gao, Xu, Wang, The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study, Aging
Gavrielatou, Xourgia, Xixi, Effect of vitamin C on clinical outcomes of critically ill patients with COVID-19: an observational study and subsequent meta-analysis, Front Med
Gavriilaki, Anyfanti, Gavriilaki, Lazaridis, Douma et al., Endothelial dysfunction in COVID-19: lessons learned from coronaviruses, Curr Hypertens Rep
Hakamifard, Soltani, Maghsoudi, The effect of vitamin E and vitamin C in patients with COVID-19 pneumonia; a randomized controlled clinical trial, Immunopathol Persa
Hartel, Strunk, Bucsky, Schultz, Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes, Cytokine
Hemila, Chalker, Vitamin C can shorten the length of stay in the ICU: a meta-analysis, Nutrients
Hemila, Chalker, Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis, J Intensive Care
Hess, Halalau, Dokter, High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19, Intern Emerg Med
Hiedra, Lo, Elbashabsheh, The use of IV vitamin C for patients with COVID-19: a case series, Expert Rev Anti Infect Ther
Holford, Carr, Vitamin C-an adjunctive therapy for respiratory infection, sepsis and COVID-19, Nutrients
Hossen, Barek, Jahan, Islam, A review on current repurposing drugs for the treatment of COVID-19: reality and challenges, SN Compr Clin Med
Huang, Wang, Li, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Huang, Wang, Tan, Liu, Ni, High-dose vitamin C intravenous infusion in the treatment of patients with COVID-19: a protocol for systematic review and meta-analysis, Medicine
Jamalimoghadamsiahkali, Zarezade, Koolaji, Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial, Eur J Med Res
Khan, Mallhi, Alotaibi, Threat of COVID-19 vaccine hesitancy in Pakistan: the need for measures to neutralize misleading narratives, Am J Trop Med Hyg
Kim, Jo, Eom, Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: propensity score-based analysis of a before-after cohort study, J Crit Care
Kim, Kim, Bae, Vitamin C is an essential factor on the anti-viral immune responses through the production of interferon-α/ β at the initial stage of influenza A virus (H3N2) infection, Immune Netw
Kim, The sociology of longevity: Socioecological factors of survival probability
Kouhpayeh, Shariati, Boshtam, The molecular basis of covid-19 pathogenesis, conventional and nanomedicine therapy, Int J Mol Sci
Krishnan, Patel, Desai, Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia, J Clin Anesth
Kumari, Dembra, Dembra, The role of vitamin C as adjuvant therapy in COVID-19, Cureus
Kwak, Choo, Mc, The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: a systematic review and meta-analysis, Complement Ther Med
Lan, Ge, Yu, Structure of the SARS-CoV-2 spike receptorbinding domain bound to the ACE2 receptor, Nature
Leblanc, Côté, Pagé, Implementation of nurse-driven HIV screening targeting key populations in emergency departments: a multilevel analysis from the DICI-VIH trial, Worldviews Evid Based Nurs
Li, Ching, Hipple, Lopez, Sahibzada et al., Use of intravenous vitamin C in critically ill patients with COVID-19 infection, J Pharm Pract
Lu, Zhao, Li, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet
Lykkesfeldt, On the effect of vitamin C intake on human health: how to (mis) interprete the clinical evidence, Biol
Marik, Khangoora, Rivera, Hooper, Catravas, Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study, Chest
Milani, Macchi, Guz-Mark, Vitamin C in the treatment of COVID-19, Nutrients
Mousavi, Bereswill, Heimesaat, Immunomodulatory and antimicrobial effects of vitamin C, Eur J Microbiol Immunol
Ouzzani, Hammady, Fedorowicz, Elmagarmid, Rayyan-a web and mobile app for systematic reviews, Syst Rev
Piraveenan, Sawleshwarkar, Walsh, Optimal governance and implementation of vaccination programmes to contain the COVID-19 pandemic, R Soc Open Sci
Rawat, Roy, Maitra, Gulati, Khanna et al., Vitamin C and COVID-19 treatment: a systematic review and meta-analysis of randomized controlled trials, Diabetes Metab Syndr
Ruan, Yang, Wang, Jiang, Song, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med
Schorah, Downing, Piripitsi, Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients, Am J Clin Nutr
Shang, Ye, Shi, Structural basis of receptor recognition by SARS-CoV-2, Nature
Song, Shi, Shan, Emerging 2019 novel coronavirus (2019-nCoV) pneumonia, Radiology
Sulaiman, Aljuhani, Saleh, Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study, Sci Rep
Suna, Melahat, Murat, Figen, Ayperi, Effect of highdose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia, Med Clin
Thomas, Patel, Bittel, Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial, JAMA Netw Open
Uddin, Millat, Baral, The protective role of vitamin C in the management of COVID-19: a review, J Egypt Public Health Assoc
Walls, Park, Tortorici, Wall, Mcguire et al., Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell
Wells, Shea, Connell, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses
Wu, Mcgoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA
Zabetakis, Lordan, Norton, Tsoupras, COVID-19: the inflammation link and the role of nutrition in potential mitigation, Nutrients
Zhang, Bastard, Cobat, Casanova, Human genetic and immunological determinants of critical COVID-19 pneumonia, Nature
Zhang, Rao, Li, Pilot trial of high-dose vitamin C in critically ill COVID-19 patients, Ann Intensive Care
Zhang, Xiang, Huo, Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy, Signal Transduct Target Ther
Zhang, Zhao, Zhang, The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China, Clin Immunol
Zhao, Liu, Liu, High dose intravenous vitamin C for preventing the disease aggravation of moderate COVID-19 pneumonia. A retrospective propensity matched before-after study, Front Pharmacol
Zhou, Yang, Wang, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature
Zhou, Yu, Du, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop